Add time:07/19/2019 Source:sciencedirect.com
ObjectivesThe purpose of this study was to document the results of Bleomycin A5 (cas 11116-32-8) sclerotherapy for cervicofacial lymphatic malformations (LMs), and the clinical data of 65 patients between October 2004 and October 2007 were reviewed.
We also recommend Trading Suppliers and Manufacturers of Bleomycin A5 (cas 11116-32-8). Pls Click Website Link as below: cas 11116-32-8 suppliers
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View